Consensus AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
5.87 USD +2.98% Intraday chart for AngioDynamics, Inc. +6.34% -25.13%

Evolution of the average Target Price on AngioDynamics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1171adb6998bd8ecc9c5fd9a97.GR9lN3YYIm3Lp3-5H0nYT68ta__0OQ-1YIVL8lWp_F4.W2koWydra1rywTyMXivoLPVEBZ6YCE3zK9o-mGeemg1OJipmHilEParxFA~734aa923f3c6aacbca620da8a866b69c
Raymond James Adjusts Price Target on AngioDynamics to $10 From $12, Maintains Outperform Rating MT
HC Wainwright Adjusts Price Target on AngioDynamics to $18 From $20, Keeps Buy Rating MT
Raymond James Adjusts Price Target on AngioDynamics to $12 From $13, Keeps Outperform Rating MT
HC Wainwright Adjusts AngioDynamics' Price Target to $20 From $19, Keeps Buy Rating MT
HC Wainwright Starts AngioDynamics at Buy With $19 Price Target MT
Canaccord Genuity Adjusts AngioDynamics Price Target to $20 From $18, Maintains Buy Rating MT
Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Target to $13 From $14 MT
Raymond James Adjusts Price Target on AngioDynamics to $14 From $22, Maintains Strong Buy Rating MT
Raymond James Adjusts AngioDynamics' Price Target to $22 From $25, Keeps Strong Buy Rating MT
Raymond James Adjusts AngioDynamics' Price Target to $25 from $27, Maintains Strong Buy Rating MT
Raymond James Adjusts AngioDynamics' Price Target to $27 from $32, Keeps Strong Buy Rating MT
ANGIODYNAMICS : Canaccord Genuity Upgrades AngioDynamics to Buy From Hold, Lifts Price Target to $37 From $28 MT
ANGIODYNAMICS : Oppenheimer Initiates Coverage on AngioDynamics With Perform Rating MT
ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $28 From $24, Maintains Hold Rating MT
ANGIODYNAMICS : Raymond James Adjusts AngioDynamics' Price Target to $32 From $27, Keeps Strong Buy Rating MT
ANGIODYNAMICS : Raymond James Adjusts AngioDynamics' Price Target to $27 from $24, Keeps Strong Buy Rating MT
ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $24 From $18, Maintains Hold Rating MT
ANGIODYNAMICS : Raymond James Upgrades AngioDynamics to Strong Buy From Market Perform; Price Target is $18 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
5.87 USD
Average target price
14 USD
Spread / Average Target
+138.50%
High Price Target
18 USD
Spread / Highest target
+206.64%
Low Price Target
10 USD
Spread / Lowest Target
+70.36%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AngioDynamics, Inc.

Raymond James
HC Wainwright
Canaccord Genuity
Oppenheimer
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings